Related Experiment Video

Updated: Jun 20, 2026

Left Atrial Stenosis Induced Pulmonary Venous Arterialization and Group 2 Pulmonary Hypertension in Rat
08:34

Left Atrial Stenosis Induced Pulmonary Venous Arterialization and Group 2 Pulmonary Hypertension in Rat

Published on: November 18, 2018

[Pulmonary hypertension and pulmonary circulation in congenital heart disease]

I Schulze-Neick1, H Kaemmerer

  • 1UK Service for Pulmonary Hypertension in Children, Great Ormond Street Hospital, London. NeickI@gosh.nhs.uk

Deutsche Medizinische Wochenschrift (1946)
|September 1, 2009
PubMed

Insights

Congenital heart defects can lead to pulmonary arterial hypertension. New medications targeting pulmonary circulation improve outcomes for adults with these complex conditions.

Area of Science:

  • Cardiology
  • Pulmonary Medicine
  • Vascular Biology

Context:

  • Congenital cardiac malformations frequently involve pulmonary hypertension and vascular changes.
  • Pulmonary arterial hypertension affects 5-10% of adults with congenital heart disease, ranging from mild to severe (Eisenmenger reaction).
  • Limited medical treatment options were previously available for these patients.

Purpose:

  • To review the current understanding and treatment of pulmonary hypertension associated with congenital heart disease.
  • To highlight the impact of novel pulmonary vasoactive and antiproliferative agents.
  • To emphasize the need for specialized care in managing these complex cases.

Summary:

  • New therapeutic agents, including endothelin receptor antagonists, phosphodiesterase-5 inhibitors, and prostanoids, offer improved treatment for pulmonary hypertension in congenital heart disease.
  • These medications address endothelial dysfunction and antiproliferative pathways, enhancing outcomes.
  • Even patients with severe malformations like Fontan circulation or pulmonary atresia can benefit.

Impact:

  • Advances in medical therapy offer new hope for patients with complex congenital heart disease and pulmonary hypertension.
  • Improved treatment strategies can lead to better quality of life and prognosis for affected individuals.
  • Management requires specialized multidisciplinary care in dedicated congenital heart disease centers.

More Related Videos

Increasing Pulmonary Artery Pulsatile Flow Improves Hypoxic Pulmonary Hypertension in Piglets08:08

Increasing Pulmonary Artery Pulsatile Flow Improves Hypoxic Pulmonary Hypertension in Piglets

Published on: May 11, 2015

Related Concept Videos

Pulmonary Hypertension: Classification and Pathogenesis01:30

Pulmonary Hypertension: Classification and Pathogenesis

Pulmonary hypertension (PH) is a severe health condition in which the mean pulmonary arterial pressure increases to 25 mmHg or more, even when the body is at rest. This high pressure in the blood vessels that transport blood from the heart to the lungs can cause various symptoms, including shortness of breath, can lead to right heart failure, and significantly affect the overall quality of life.
There are various classifications for PH, each relating to different underlying causes and also...
Overview of Systemic and Pulmonary Circulation01:15

Overview of Systemic and Pulmonary Circulation

The systemic and pulmonary circuits are crucial components of the circulatory system, working together to transport blood between the heart, lungs, and the rest of the body. The process begins with pulmonary circulation, where deoxygenated blood is pumped from the right ventricle to the lungs via the pulmonary trunk and arteries. Upon reaching the lungs, the blood becomes oxygenated and returns to the heart, specifically to the left atrium, via the pulmonary veins.
The oxygenated blood is sent...
Overview of Pulmonary Circulation01:19

Overview of Pulmonary Circulation

The pulmonary circulation is a vital system in our body that acts as a bridge between the respiratory and cardiovascular systems. It serves as a transport network for deoxygenated blood from the heart to the lungs and then returns oxygen-rich blood back to the heart.
The process begins with the right ventricle of the heart pumping deoxygenated blood into the pulmonary trunk. This large vessel extends about 5 centimeters before splitting into the left and right pulmonary arteries. These arteries...
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
Fetal Circulation01:14

Fetal Circulation

Fetal circulation is a unique system that facilitates the exchange of gases, nutrients, and waste products between the developing fetus and the mother. This intricate process takes place through a special organ called the placenta.
Two umbilical arteries transport blood from the fetus to the placenta. At the placenta, the blood absorbs oxygen and nutrients while simultaneously eliminating waste products. This oxygen-enriched and nutrient-rich blood then returns to the fetus through one...